Pfizer: Getting that 4th or 5th Booster is great for “Omicron” and even better for Stock price


During an interview on CNBC’s Squawk Box, Pfizer CEO Albert Bourla appeared to contradict his own company’s data by claiming that his company’s jab will “not lose any efficacy against omicron” because the “mode of action is not on the spike…it’s working on a different element of the virus.”

However, data out of South Africa appears to show that even patients who have been vaccinated are testing positive for omicron. And keep in mind, the lab-only results Pfizer shared today aren’t nearly as reliable.

He’s doing his job – trying to sell more vaccines.

* * *

Last night, data released out of South Africa showed that the Pfizer vaccine, supposedly the world’s gold standard in terms of COVID jabs, was less effective against the omicron variant than earlier variants of SARS-CoV-2.

And on Wednesday morning, Pfizer and its partner BioNTech pushed back by releasing data showing that three full doses of their best-selling jab were effective enough to neutralize the omicron variant in lab tests (not in actual humans).

However, two vaccine doses resulted in significantly lower neutralizing antibodies but that a third dose of their vaccine increased the neutralizing antibodies by a factor of 25. Using blood obtained from patients that had their booster shot a month ago, the scientists found that it neutralized the Omicron variant about as effectively as blood after two doses fought off the original Wuhan strain.